Clinical Trial Update: Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating vandetanib with radiation therapy in young patients with newly diagnosed diffuse brainstem glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Vandetanib (vandetanib)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED